Six months ago, a rep selling into a dental practice could count on 15 minutes with the owner and a website demo request to start the deal. That's not how a growing share of these deals start anymore.
Ask any vendor selling into multi-location dental or optometry groups where their last five deals actually began, and the honest answer is increasingly the same: an approved vendor list, built by a clinical operations director at group headquarters, months before any individual practice ever saw a demo.
This is the shift most health practice tech content still isn't written for.
The buyer changed before the content did
DSO and MSO consolidation has been reshaping who signs the contract for a few years now. Most vendors adjusted their sales targeting accordingly: fewer individual owner pitches, more conversations with regional or corporate decision makers.
What's changed more recently, and what fewer vendors have caught up to, is how those centralized buyers actually evaluate software. A group with 40 locations doesn't run 40 separate procurement processes. It runs one, usually managed by a clinical ops or IT director, and the output is a shortlist: the approved vendor list every location is expected to choose from.
Getting onto that list, or getting left off it, now decides more revenue than any individual practice pitch ever will.
Why the shift is accelerating
Three forces are pushing group leadership to centralize software decisions instead of leaving them to individual locations.
Staffing shortages make vendor sprawl expensive. When an office manager moves between locations, or a group hires centrally and deploys staff wherever they're needed, every extra tool a location runs on its own is another system that new staff has to learn from scratch.
Data and compliance exposure make it worse. A location running an unapproved tool with access to patient data is a liability headquarters didn't sign off on. Centralizing the vendor list is partly a growth decision and partly a risk decision.
And roll-up economics reward standardization. A PE-backed group buying up independent practices needs the acquired locations to run on the same systems as everywhere else, fast, so the group can actually realize the operating efficiencies the deal was priced on.
None of these forces are slowing down. If anything, they compound as groups get bigger.
How the list actually gets built
The mechanics vary by group size, but the pattern holds. A clinical ops director, sometimes paired with a procurement or IT lead, builds a shortlist of 3 to 5 vendors per category: practice management, patient communication, imaging, payments. That shortlist runs through a pilot at one or two flagship locations, usually over a few months.
If the pilot holds up, the vendor gets added to the approved list, and every location gets access, and pressure, to adopt it. If it doesn't, or if a vendor was never invited to pilot in the first place, that category gets decided without them.
These lists aren't rebuilt often. Once a group has been through the pain of a multi-site rollout, there's little appetite to reopen the category next year. A vendor that lands on the list is often protected from a full re-evaluation for two or three years. A vendor left off it is locked out for roughly the same stretch.
That's what makes this worth taking seriously now rather than reacting to it later. The window to get evaluated closes, and it stays closed for a while.
Getting invited to the pilot in the first place
Landing on an approved vendor list starts earlier than most vendors assume. Clinical ops directors don't usually open a formal RFP process from a blank sheet. They start with a shortlist they've already half-built in their head, based on who they've come across in the last year, whose name a peer at another group mentioned, whose content actually answered a question they had.
That's the quiet part of this shift. The pilot invitation is downstream of visibility that happened months earlier, often through content the director found on her own, not through a cold outreach sequence timed to when she happened to be evaluating.
A vendor with no presence in front of this audience isn't in the room when the shortlist gets drafted. It doesn't matter how strong the product is if the person building the list has never heard of the company by the time she starts writing names down.
Why this breaks most existing funnels
Most health practice tech content still speaks to the individual practice owner: her pain points, her patient volume, her staffing headaches. That content still matters. Independent practices are still buying, and owners still make up a real share of the market.
But it's the wrong content for a clinical ops director evaluating a category across 40 sites. Picture a patient communication vendor with a strong content library built entirely around the solo-owner journey: reducing no-shows, automating recall reminders, freeing up front desk time. Every post assumes one location and one decision maker.
A clinical ops director googling how to evaluate patient communication vendors for a 30-location rollout finds none of it useful. She's not weighing whether the tool solves one practice's Tuesday. She's weighing implementation timeline across sites with different EHRs, whether the vendor has a dedicated account manager for multi-location accounts, how data migration works at scale, and whether groups her size have already run this vendor through a full rollout. She moves on to a competitor whose content actually answers those questions, and the first vendor never even knows it lost the evaluation.
What the evaluation actually checks for
Four things come up in nearly every group-level evaluation, and they're worth building content around directly.
Standardization across sites. Can this tool run the same way at a 3-chair practice and a 40-chair flagship, or does it need custom configuration per site? Groups want one answer, not 40.
Integration with what's already installed. A group with an existing imaging or billing system isn't ripping it out for a new patient communication tool. The evaluation checks compatibility, not features in isolation.
Rollout support, not just onboarding. Onboarding one practice and rolling out to 40 locations over 6 months are different projects. Groups want to see a vendor has done the second one before.
References from groups their size. A testimonial from a single independent practice carries almost no weight in this evaluation. A reference call with another 30-location group that ran the same rollout carries a lot.
What this means for content strategy
If a piece of content only speaks to the practice owner, it never reaches the person building the shortlist. That doesn't mean abandoning owner-focused content. It means adding a second track that speaks directly to clinical ops and IT decision makers at multi-location groups, with a different voice, different proof points, and a different distribution plan.
A few things worth building specifically for this buyer:
- An implementation and rollout overview that answers the multi-site question before it's asked, not after a sales call.
- Case studies structured around groups, not individual practices: site count, systems already in place, rollout timeline, who owned the project internally.
- A short reference list of similarly sized groups willing to take a call, built and maintained before it's needed, not scrambled together during a live evaluation.
- Content aimed at the job titles actually running the shortlist: clinical operations director, VP of clinical operations, dental group IT lead. Most vendor content is written for "practice owner" as a persona and never mentions these roles at all.
None of this needs to replace the existing owner-focused funnel. It runs alongside it, aimed at a different reader with a different job to do.
What to do this quarter
This doesn't need a full rebuild of the content calendar to start. A useful first pass looks like this.
Pull the last 10 to 15 deals and check how many involved a group with more than 3 locations. If that share is growing, the shortlist buyer is already showing up in the pipeline, whether or not the funnel was built for her.
Write one piece for the clinical ops director specifically. Not a rewrite of an owner-focused post with different pronouns. A piece that answers a question only someone running a multi-site evaluation would ask, like what a rollout actually costs in staff hours per location, or how data migration gets handled when three locations run three different EHRs.
Ask the sales team which groups have asked for references in the last year, and start building relationships with two or three of those groups now, before the next evaluation needs them on short notice.
None of this replaces the work of building trust with individual owners. It sits next to it, aimed at the buyer who increasingly decides the deal before an owner ever sees a demo.
The opening this creates
Almost nobody selling into health practice tech is writing for this buyer yet. Most competitors are still optimizing content for the independent owner because that's who used to make every decision, and old habits are sticky.
That's the opening. The vendor who publishes the first genuinely useful breakdown of what a multi-location rollout actually looks like, or the first honest guide to what a clinical ops director should ask before adding a vendor to a shortlist, gets remembered the next time a group starts building one.
Owning that topic now, while almost no one else in the category has claimed it, is worth more than another article aimed at an owner persona that's shrinking as a share of the buying decision. The group evaluating vendors next quarter is already forming an opinion about who understands this shift and who's still writing for a market that used to exist.